Overview of the systematic reviews with network meta-analysis evaluating the efficacy or safety of the systemic treatments in moderate-to-severe psoriasis

被引：0
|
作者：
Guelimi, Robin [1 ]
Afach, Sivem [1 ]
Regnaux, Jean-Philippe [1 ]
机构：
[1] Univ Paris Est Creteil, UPEC EpiDermE EA, Creteil, France
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
33567
引用
收藏
页码：AB88 / AB88
页数：1
相关论文
共 50 条
  • [31] Meta-analysis of the efficacy and safety of secukinumab in the treatment of moderate to severe psoriasis
    Cai, Yanxia
    Deng, Shiyin
    Luo, Yaqi
    Deng, Liehua
    AIP ADVANCES, 2025, 15 (01)
  • [32] Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta-analysis
    Hu, Caixia
    Han, Xiaomei
    Cui, Yu
    Zhang, Yan
    Cheng, Yi
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (08)
  • [33] Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis
    Xu, Shanshan
    Gao, Xing
    Deng, Jixiang
    Yang, Jiajia
    Pan, Faming
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (01): : 47 - 56
  • [34] Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
    Yan, Ting
    Wang, Ting
    Tang, Mei
    Liu, Nan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
    Singh, Siddharth
    Murad, M. Hassan
    Fumery, Mathurin
    Sedano, Rocio
    Jairath, Vipul
    Panaccione, Remo
    Sandborn, William J.
    Ma, Christopher
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 1002 - 1014
  • [36] Network meta-analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis
    Qiu, Mei
    Duan, Xue-Yan
    Yin, Dao-Gen
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (01) : E24 - E26
  • [37] Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Vassilis Stakias
    Luis Puig
    Dermatology and Therapy, 2022, 12 : 167 - 184
  • [38] Efficacy and safety of guselkumab for the treatment of patients with moderate-to-severe plaque psoriasis: A meta-analysis of randomized clinical trials
    Tao, Xing-Bao
    Huang, Yin-Qiu
    Zhou, Yi-Hong
    Zhang, Lv-Lang
    Chen, Yao-Kai
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (02) : 433 - 440
  • [39] Comparative efficacy and safety of JAK/TYK2 inhibitors and other oral drugs for moderate-to-severe plaque psoriasis: Systematic review and network meta-analysis
    Zheng, Yaxuan
    Han, Yue
    Chen, Jincong
    Huang, Jiahao
    Zhu, Changhua
    Lin, Lihang
    Su, Huichun
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (05): : 590 - 598
  • [40] Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
    Silverberg, Jonathan I.
    Bieber, Thomas
    Paller, Amy S.
    Beck, Lisa
    Kamata, Masahiro
    Puig, Luis
    Wiseman, Marni
    Ezzedine, Khaled
    Irvine, Alan D.
    Foley, Peter
    Del Rosso, James
    Gold, Linda Stein
    Johansson, Erin
    Dossenbach, Martin
    Gallo, Gaia
    Akmaz, Buelent
    Casillas, Marta
    Karlsson, Andrei
    Curteis, Tristan
    Chovatiya, Raj
    DERMATOLOGY AND THERAPY, 2025, 15 (03) : 615 - 633
12345